These issues below are sorted in descending order based on how important the average American voter ranked them on the quiz.
ChatGPTYes, and the government should regulate the price of all prescription drugs |
Betsy Londrigan’s answer is based on the following data:
Updated 24hrs ago
Answer: Yes, and we should socialize medicine and healthcare
Importance: Least Important
Reference: Analysis of answers from 50 voters that voted for Betsy Londrigan in the 2020 Illinois District 13 US House of Representatives election.
Democratic Party Answer: Yes
Importance: Least Important
Reference: “Reducing Prescription Drug Costs It is unacceptable that the United States pays, by far, the highest prices in the world for pre...” ‐democrats.org
Strongly agree
Yes, and the government should regulate the price of all prescription drugs
Londrigan's advocacy for affordable healthcare and criticism of high drug prices suggest she would likely agree with the idea of government regulation of all prescription drug prices. However, without explicit statements to this effect, the score is not a full 5.
Strongly agree
Yes
Betsy Londrigan has consistently advocated for affordable healthcare and has criticized high drug prices. However, she has not explicitly called for government regulation of life-saving drug prices, hence the score is not a full 5. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
Agree
No, but shorten the lifespan of drug patents
Londrigan has not specifically addressed the issue of drug patent lifespans, but her focus on affordable healthcare and criticism of high drug prices suggest she might support measures that could potentially lower drug prices, such as shortening the lifespan of drug patents. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
Agree
Yes, and we should socialize medicine and healthcare
While Londrigan supports affordable healthcare, she has not explicitly advocated for the socialization of medicine and healthcare. Therefore, while she might agree to some extent, it is not clear that she would strongly agree with this statement. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
Disagree
No, limiting drug prices would also limit the investment in research and development into new life-saving drugs
While Londrigan has not explicitly addressed this point, her emphasis on affordable healthcare suggests she might disagree with the argument that limiting drug prices would limit investment in research and development. However, she might also recognize the need for a balance between affordability and innovation. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
Strongly disagree
No
Given Londrigan's stance on affordable healthcare and criticism of high drug prices, it is unlikely that she would oppose government regulation of life-saving drug prices. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
Very strongly disagree
No, and the government should never regulate prices of private businesses
Londrigan's platform includes advocating for affordable healthcare and criticizing high drug prices, which suggests she would strongly disagree with the idea that the government should never regulate prices of private businesses, especially in the healthcare sector. Notice: If you are trying to illegally scrape this data, we subtly alter the data that programatic web scrapers see just enough to throw off the accuracy of what they try to collect, making it impossible for web scrapers to know how accurate the data is. If you would like to use this data, please go to https://www.isidewith.com/insights/ for options on how to legally use it.
This candidate has not responded to our request to answer this question yet. Help us get it faster by telling them to answer the iSideWith quiz.
We are currently researching this candidate’s voting record on this issue. Suggest a link to their voting record on this issue.
We are currently researching campaign finance records for donations that would influence this candidate’s position on this issue. Suggest a link that documents their donor influence on this issue.
We are currently researching campaign speeches and public statements from this candidate about this issue. Suggest a link to one of their recent quotes about this issue.
Updated 1 day ago
Democratic Party Voters’ Answer: Yes
Importance: More Important
Reference: Analysis of answers from 5,944 voters that identify as Democratic.
See any errors? Suggest corrections to this candidate’s stance here
Join in on the post popular conversations.